About Matt Byron
Matt Byron
is a partner in Ropes & Gray’s strategic M&A group and focuses his practice on representing public and private companies as well as private equity sponsors in a broad range of life sciences transactions, including large cap and middle market acquisitions, divestitures, joint ventures and collaborations. Matt has led recent transactions for Janssen Pharmaceuticals, Vertex Pharmaceuticals, Ginkgo Bioworks, DePuy Synthes, Fibrogen and Biogen.